July 11, 2026 a 08:38 am

GEHC: Analysts Ratings - GE HealthCare Technologies Inc.

Historical Stock Grades

Recent data indicates a favorable position for the GEHC stock among analysts, highlighted by a decent number of strong buy and buy ratings. The lack of any sell or strong sell ratings further signifies market confidence at this juncture.

Recommendation	Quantity	Score
Strong Buy	4
Buy	9
Hold	5
Sell	0
Strong Sell	0

Sentiment Development

Over recent months, the analyst sentiment for GEHC has shown a gradual stabilization. While strong buy recommendations have remained consistent, there is a noticeable adjustment with an increase in hold ratings, reflecting a more cautious optimism.

• The total number of ratings remains relatively stable, indicating a sustained interest from analysts.
• Hold ratings have seen a slight increase, which may signify a growing need for reassessment amid evolving market conditions.
• The mix of buy and hold ratings suggests balanced sentiment, avoiding extreme bearish or bullish outlooks.

Percentage Trends

The percentage of buy ratings has shown variance over the past few months, leading to an altered distribution of analyst opinions. This marks a shift towards a more conservative appraisal of GEHC's market prospects.

• Distribution analysis shows 44% Buy and 22% Strong Buy, a significant attraction from analysts.
• Hold ratings increased to 34% recently, indicating caution.
• This recalibration underscores an industry-wide trend toward risk mitigation visible in market behavior.

Latest Analyst Recommendations

Recent analyst recommendations for GEHC indicate stable sentiments, with most ratings being maintained. However, isolated upgrades suggest emerging confidence in certain areas.

Date	New Recommendation	Last Recommendation	Publisher
2026-05-21	Neutral	Sell	UBS
2026-04-30	Neutral	Neutral	JP Morgan
2026-04-30	Neutral	Neutral	Citigroup
2026-04-30	Equal Weight	Equal Weight	Barclays
2026-04-30	Overweight	Overweight	Wells Fargo

Analyst Recommendations with Change of Opinion

This section highlights shifts in analyst opinions over time, revealing sentiments closer to neutrality in some cases, pointing to evolving perspectives within the analyst community.

Date	New Recommendation	Last Recommendation	Publisher
2026-05-21	Neutral	Sell	UBS
2026-04-30	Neutral	Buy	Goldman Sachs
2026-01-15	Sell	Neutral	UBS
2025-10-07	Neutral	Buy	Citigroup
2025-05-05	Neutral	Sell	UBS

Interpretation

The current trend in GEHC's analyst ratings indicates a stable yet cautious optimism. The presence of various strong buy and buy suggestions reflects confidence, but the increased hold recommendations hint at measured caution and re-evaluation. As the healthcare industry faces unprecedented change, analyst sentiment appears to indicate steady, albeit careful, approval of GEHC's market dynamics. While immediate uncertainty in the ratings is low, it remains vital to monitor shifts for future trends.

Conclusion

GE HealthCare Technologies Inc. portrays a promising outlook with prevailing buy ratings. However, the cautious uptick in hold recommendations suggests analysts are hedging against potential market uncertainties. Strategic placements within its diversified business units may drive future growth, yet evolving industry challenges necessitate careful navigation. Thus, while GEHC remains a sound prospect, ongoing fiscal vigilance and market adaptation are imperative for sustained stability and growth.